 |
|
|
 |
|
Younger Women With Hereditary Breast Cancer Risk Tumor in Other Breast
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 The study findings suggest that several courses of action are wise, Gronberg said. "Young women, those under age 50, with hereditary breast cancer, regardless of BRCA1/2 mutation status, should consider a prophylactic operation in the opposite breast within two to three years after the treatment of the first cancer," he said. "This will reduce the risk of being diagnosed with a new breast cancer in the opposite breast."
For women over age 50, he said, "the need for prophylactic surgery is much less, and the use of adjuvant hormonal therapy is most appropriate among these women."
Genetic counseling is also important for women with hereditary breast cancer, Gronberg said.
Text Continues Below

The study results probably won't surprise those in the genetic-counseling field, said Scott Weissman, a certified genetics counselor and co-chairman of the familial cancer risk counseling special interest group for the National Society of Genetic Counselors.
Genetic counseling can help women decide what options to pursue, he said. "We try to identify the mutation in a gene causing a breast cancer in the family," he said. "If we are able to identify one, we can counsel these women about their chances of getting a cancer in the opposite breast."
"You can very much put numbers on it," Weissman said. Women can be told their chances of getting another cancer in specific percent terms, over a specific time period, he said.
"Genetics counseling can help guide you on how to manage the risk," he said. That might mean more frequent screening for breast cancer or adding a breast MRI to regular mammograms.
More information
To learn more about genetic counseling, visit the National Society of Genetic Counselors (www.nsgc.org ).
Page: << Prev | 1 | 2
|
Copyright © 2006 ScoutNews LLC. All rights reserved.
Last updated 2/15/2006
| | | MyBreastCancerNetwork.com - Information on breast cancer: signs and symptoms, breast health, and breast cancer drugs and treatments. Join a community of breast cancer support and stories. |
|
 |

SOURCES: Henrik Gronberg, M.D., Ph.D., professor, cancer epidemiology, Karolinska Institute, Stockholm, Sweden; Scott Weissman, certified genetic counselor, Northwestern Healthcare, Evanston, Ill., and co-chairman, familial cancer risk counseling special interest group, National Society of Genetic Counselors; March 15, 2006, Cancer
|